Evidence map›Paper›PMID 38241178›Full record

ArticleCancer biology & therapy2024

The facilitating effects of KRT80 on chemoresistance, lipogenesis, and invasion of esophageal cancer.

Wen-Jing Yun, Jun Li, Nan-Chang Yin, Cong-Yu Zhang, Zheng-Guo Cui, Li Zhang, Hua-Chuan Zheng

Open access · goldAbstract read
In one paragraph

Article in Cancer biology & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Wen-Jing YunDepartment of Oncology, The Affiliated Hospital of Chengde Medical University, Chengde, China.
Jun LiDepartment of Thoracic Surgery, Shandong Provincial Hospital, Jinan, China.
Nan-Chang YinDepartment of Thoracic Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Cong-Yu ZhangCancer Center, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Zheng-Guo CuiDepartment of Environmental Health, University of Fukui School of Medical Sciences, Fukui, Japan.
Li ZhangDepartment of Oncology, The Affiliated Hospital of Chengde Medical University, Chengde, China.
Hua-Chuan ZhengDepartment of Oncology, The Affiliated Hospital of Chengde Medical University, Chengde, China.ORCID 0000-0003-0965-6818
Chengde Medical University · CNJinzhou Medical University · CNShandong Provincial Hospital · CNUniversity of Fukui · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Keratin 80 (KRT80) is a filament protein that makes up one of the major structural fibers of epithelial cells, and involved in cell differentiation and epithelial barrier integrity. Here, KRT80 mRNA expression was found to be higher in esophageal cancer than normal epithelium by RT-PCR and bioinformatics analysis (

Indexed as

Drug Resistance, NeoplasmEsophageal NeoplasmsKeratins, Type IICell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticHumansLipogenesisRNA, MessengerKeratins, Type IIKRT80 protein, humanRNA, Messengerbiological behaviorsEsophageal cancergene therapyKRT80prognosis

Identifiers

PMID38241178
PMCPMC10802210
OpenAlexW4391035485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.